TY  - BOOK
AU  - Shereen Hassan Mohamed Aboul Naga
AU  - Johann Roider , 
AU  - Mahmoud M. Soliman , 
AU  - Tamer Macky , 
TI  - Intracellular uptake and storage of bevacizumab in retinal pigment epithelia / 
PY  - 2015///
CY  - Cairo : 
PB  - Shereen Hassan Mohamed Aboul Naga , 
KW  - Bevacizumab
KW  - F-actin cytoskeleton
KW  - RPE
N1  - Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Ophthalmology; Issued also as CD
N2  - Bevacizumab (Avastin®), an anti-VEGF antibody, is used in the treatment of age related macular degeneration, one of the leading causes of legal blindness in the elderly population in the Western world. It was found, that bevacizumab is taken up and stored in vitro in the porcine retinal pigment epithelial (RPE) cells model. In this study, the uptake and intracellular localization of bevacizumab are investigated via immunofluorescence and Western Blot studies, in order to elucidate the underlying mechanism of degradation and storage and possible relevance in vivo. Ultimately, this study attempts to determine the pathophysiology of RPE and bevacizumab interaction and the related pathways, and in combining the data with clinically relevant questions, a better understanding of the function of RPE cells as well as determining potential side effects of anti-VEGF therapy can be reached
ER  -